Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.

Senseonics has filed to obtain CE Mark registration for its one-year continuous glucose monitoring (CGM) system, Eversense 365. The CE Mark submission aligns with the EU Medical Device Regulation (MDR ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Artificial intelligence (AI) is transforming dietary management for diabetes and obesity, offering personalized nutrition plans, real-time glucose mon.

US FDA alerts patients of potential to miss critical safety alerts due to phone settings when using smartphone-compatible diabetes devices: Maryland Friday, February 7, 2025, 09:0 ...

Health-related technologies have evolved significantly in the modern world, offering people innovative tools to manage their ...

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

The FDA issued an alert warning diabetes patients and caregivers about potential issues with smartphone alerts for continuous glucose monitors.

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...